FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders

October 04, 2023 -- Today, the U.S. Food and Drug Administration published a new draft guidance to assist sponsors in developing treatments for stimulant use disorders. The guidance, Stimulant Use Disorders: Developing Drugs for Treatment, when...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials